Zacks Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.5M Sell
84,157
-1,466
-2% -$397K 0.18% 122
2025
Q4
$21.5M Buy
85,623
+1,936
+2% +$514K 0.17% 132
2025
Q3
$24M Buy
83,687
+2,318
+3% +$621K 0.19% 124
2025
Q2
$21.4M Buy
81,369
+323
+0.4% +$78.7K 0.18% 129
2025
Q1
$18.9M Buy
81,046
+2,804
+4% +$680K 0.18% 135
2024
Q4
$17.9M Sell
78,242
-9,461
-11% -$2.17M 0.17% 137
2024
Q3
$19.6M Buy
87,703
+10,125
+13% +$2.23M 0.17% 134
2024
Q2
$15.8M Buy
77,578
+6,361
+9% +$1.29M 0.18% 127
2024
Q1
$15.6M Buy
71,217
+5,577
+8% +$1.23M 0.17% 134
2023
Q4
$14.9M Buy
65,640
+845
+1% +$178K 0.18% 120
2023
Q3
$13M Sell
64,795
-30,514
-32% -$6.44M 0.17% 129
2023
Q2
$19.8M Buy
95,309
+2,127
+2% +$413K 0.25% 98
2023
Q1
$18.4M Buy
93,182
+4,403
+5% +$906K 0.25% 104
2022
Q4
$18M Buy
88,779
+722
+0.8% +$141K 0.25% 92
2022
Q3
$15.5M Sell
88,057
-1,737
-2% -$356K 0.25% 96
2022
Q2
$18.1M Buy
89,794
+2,636
+3% +$562K 0.28% 90
2022
Q1
$19.7M Sell
87,158
-1,616
-2% -$380K 0.27% 92
2021
Q4
$24M Sell
88,774
-12,195
-12% -$3.02M 0.34% 83
2021
Q3
$24.4M Buy
100,969
+2,564
+3% +$646K 0.39% 77
2021
Q2
$23.3M Sell
98,405
-21,151
-18% -$4.82M 0.38% 78
2021
Q1
$26.2M Buy
119,556
+6,207
+5% +$1.25M 0.47% 70
2020
Q4
$19.8M Buy
113,349
+33,253
+42% +$5.74M 0.37% 81
2020
Q3
$13M Buy
80,096
+8,092
+11% +$1.28M 0.26% 100
2020
Q2
$10.3M Buy
72,004
+17,984
+33% +$2.49M 0.23% 107
2020
Q1
$5.87M Sell
54,020
-1,676
-3% -$241K 0.14% 122
2019
Q4
$8.1M Sell
55,696
-359
-0.6% -$51.8K 0.15% 121
2019
Q3
$8.09M Buy
56,055
+472
+0.8% +$68.9K 0.16% 117
2019
Q2
$8.26M Buy
55,583
+72
+0.1% +$10K 0.17% 114
2019
Q1
$7.3M Buy
55,511
+1,817
+3% +$224K 0.16% 119
2018
Q4
$5.83M Sell
53,694
-2,652
-5% -$355K 0.14% 121
2018
Q3
$8.41M Buy
56,346
+621
+1% +$94.5K 0.18% 111
2018
Q2
$8.6M Buy
55,725
+19,532
+54% +$2.95M 0.19% 110
2018
Q1
$5.03M Buy
36,193
+138
+0.4% +$20.3K 0.11% 148
2017
Q4
$4.94M Sell
36,055
-17,076
-32% -$2.26M 0.11% 146
2017
Q3
$6.89M Sell
53,131
-1,044
-2% -$139K 0.16% 125
2017
Q2
$7.17M Sell
54,175
-1,505
-3% -$184K 0.18% 116
2017
Q1
$6.86M Sell
55,680
-3,777
-6% -$447K 0.17% 121
2016
Q4
$6.56M Sell
59,457
-107,500
-64% -$11.9M 0.19% 112
2016
Q3
$19.7M Buy
166,957
+2,387
+1% +$281K 0.56% 53
2016
Q2
$18.4M Sell
164,570
-1,285
-0.8% -$138K 0.56% 52
2016
Q1
$16.7M Buy
165,855
+29,909
+22% +$2.87M 0.53% 58
2015
Q4
$14.4M Buy
135,946
+3,200
+2% +$330K 0.47% 64
2015
Q3
$12.4M Buy
132,746
+13,556
+11% +$1.4M 0.43% 76
2015
Q2
$12.4M Buy
119,190
+18,035
+18% +$1.88M 0.39% 86
2015
Q1
$11M Buy
101,155
+2,430
+2% +$250K 0.35% 92
2014
Q4
$9.15M Buy
+98,725
New +$8.72M 0.3% 104

Other funds holding LH

Zacks Investment Management's LH Position: Q1 2026 in Review

Zacks Investment Management reduced its Labcorp (LH) stake by 1.7% in Q1 2026, selling an estimated $397K and leaving 84,157 shares worth $22.5M. The position accounts for 0.18% of the portfolio, ranked #122.

Zacks Investment Management first reported a position in LH in Q4 2014 and has held it in 46 quarters since. The position peaked at $26.2M in Q1 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Zacks Investment Management held 84,157 shares of Labcorp worth $22.5M as of Q1 2026.
  • Zacks Investment Management sold 1,466 Labcorp shares in Q1 2026, an estimated $397K.
  • Labcorp made up 0.18% of Zacks Investment Management's portfolio in Q1 2026, its #122 holding.
  • Zacks Investment Management first reported a position in Labcorp in Q4 2014 and has held it in 46 quarters since.
  • Zacks Investment Management's Labcorp position peaked at $26.2M in Q1 2021.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Zacks Investment Management's 13F filing for Q1 2026, filed 14 May 2026.